CELL TRANSPLANTATION is a premier multidisciplinary journal dedicated to advancing the field of regenerative medicine and transplantation, published by SAGE PUBLICATIONS INC. Since its initiation in 1992 and embracing an open-access model since 2017, the journal aims to disseminate high-quality research that covers both clinical and experimental studies on cell and tissue transplantation. With a notable impact reflected in its 2023 Q2 ranking in Biomedical Engineering and significant standings in Cell Biology and Transplantation, CELL TRANSPLANTATION serves as a vital resource for researchers, practitioners, and students alike. The journal's commitment to fostering innovation is evident in its diverse contributions that address the complexities of tissue engineering, immunology, and regenerative therapies, inviting readers to engage with cutting-edge science that is poised to transform medical practices and improve patient outcomes. The journal's insightful articles and research findings make it a crucial platform for knowledge exchange within the vibrant scientific community.

TRANSPLANT INTERNATIONAL is a premier open-access journal in the field of transplantation, published by Frontiers Media SA since 1988. With its dedicated scope encompassing the latest research and advancements in organ transplantation and related fields, this journal serves as an essential resource for researchers, clinicians, and healthcare professionals engaged in transplantation medicine. Boasting an impressive 2023 Scopus rank of #17 out of 54 in the Medicine - Transplantation category and a Q2 quartile ranking, it has established itself as a vital publication platform contributing to the global discourse on transplant innovations. As an open-access journal since 2022, TRANSPLANT INTERNATIONAL enhances the dissemination of knowledge, ensuring that pivotal findings are accessible to a broader audience, thereby fostering advancements in patient care and clinical practices. With its base in Italy and operations managed from Lausanne, Switzerland, the journal promises to remain at the forefront of transplantation research through 2024 and beyond.

The Journal of Clinical and Experimental Hepatology, published by Elsevier - Division Reed Elsevier India Pvt Ltd, is a premier platform dedicated to advancing the field of hepatology. With an ISSN of 0973-6883 and an E-ISSN of 2213-3453, this journal has gained recognition for its impactful contributions to both clinical practice and scientific research in the domain of liver health. Ranking in the Q2 quartile for Hepatology in 2023 and positioned at 33rd out of 82 in Scopus’s Hepatology category, it reflects a robust impact factor and a commitment to publishing high-quality, peer-reviewed articles. Researchers, clinicians, and students can engage with a wealth of open-access content covering the latest advancements, challenges, and insights in hepatology, as the journal aims to disseminate knowledge from 2011 through 2025. Join the community of experts as we explore critical developments in the understanding and treatment of liver diseases.

Indian Journal of Transplantation (ISSN: 2212-0017, E-ISSN: 2212-0025), published by Wolters Kluwer Medknow Publications, serves as a pivotal resource in the expanding field of transplantation medicine. As an Open Access journal since 2011, it provides unrestricted access to cutting-edge research, facilitating the dissemination of knowledge among practitioners, researchers, and students globally. With a growing focus on transplant-related advancements from 2020 to 2024, the journal has positioned itself within the Q4 category in Transplantation, underscoring its commitment to publishing valuable contributions that aim to enhance clinical practices and improve patient outcomes. Situated in the Netherlands, the journal upholds high-quality standards, inviting submissions that contribute to the understanding of various transplant procedures and practices, ultimately fostering innovation in the field. Researchers and professionals are encouraged to explore the vast array of articles, enhancing both their expertise and the community's collective knowledge in transplantation.

Vestnik Transplantologii i Iskusstvennyh Organov, published by the Federal Research Center Transplantology & Artificial Organs V I Shumakov, is an esteemed open access journal that has been disseminating critical research in the fields of transplantation and immunology since 2009. With an ISSN of 1995-1191 and E-ISSN 2412-6160, this journal serves as a vital resource for academics and practitioners alike, offering insights into current trends, innovations, and methodologies in organ transplantation. The journal is indexed in prominent databases, holding a Q4 category in Immunology and Allergy and a Q3 in Transplantation as of 2023, ranking 42nd out of 54 in the field of Medicine - Transplantation, and 208th out of 233 in Medicine - Immunology and Allergy. Through its commitment to open access publishing and its strategic focus on advancing the science of transplantology, Vestnik Transplantologii i Iskusstvennyh Organov contributes significantly to the global body of knowledge, promoting collaboration and engagement among researchers, healthcare professionals, and students from around the world.

CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION is a premier academic journal published by Lippincott Williams & Wilkins, focusing on the latest advancements and research in the fields of nephrology and hypertension. Since its inception in 1992, this journal has been an essential resource for professionals seeking to stay at the forefront of kidney health and blood pressure management. With a distinguished ranking in the top quartile (Q1) for both Internal Medicine and Nephrology as of 2023, the journal is recognized for its high impact, currently holding a Scopus rank of #16 out of 81 in Nephrology, positioning it in the 80th percentile. Although not an open access journal, it provides crucial insights and expert opinions that cater to researchers, clinicians, and students committed to improving patient outcomes through evidence-based practice. The journal continues to emphasize its objectives of disseminating pivotal findings and fostering discussions that bridge the gap between clinical practice and research, making it an invaluable asset in the evolving landscape of nephrology and hypertension.

TRANSPLANTATION PROCEEDINGS is a distinguished journal published by Elsevier Science Inc, focused on the field of transplantation and surgery. With a publication history spanning over five decades, from 1969 to 2024, this journal has consistently provided a platform for researchers and practitioners to share significant findings and advancements in organ transplantation and related surgical techniques. The journal is renowned for its rigorous peer-review process and has achieved a respectable impact factor within its categories, ranking in the Q3 quartile for both Surgery and Transplantation as of 2023. With Scopus rankings placing it in the 47th percentile in Medicine (Surgery) and the 43rd percentile in Medicine (Transplantation), TRANSPLANTATION PROCEEDINGS serves as a vital resource for academics and medical professionals seeking to stay updated on the latest empirical research, clinical practices, and innovative methodologies in the field. While it does not operate under an open-access model, the journal ensures that critical insights and data are accessible to its audience, enhancing the global discourse in transplantation science. For those dedicated to advancing transplant medicine, this journal represents an invaluable collection of knowledge and a forum for fostering innovative approaches to improve patient outcomes.

Progress in Transplantation is a leading journal published by SAGE Publications Inc, focusing on the dynamic field of transplantation medicine. With an ISSN of 1526-9248 and E-ISSN 2164-6708, this journal serves as a crucial platform for researchers and clinicians aiming to share cutting-edge findings and advancements in organ transplantation. Despite not being an Open Access journal, it provides a significant contribution to the academic community, evidenced by its placement in the Q3 category of Transplantation for 2023 and its ranking of #33 out of 54 in Scopus, showcasing a percentile standing of 39th. Progress in Transplantation has been dedicated to publishing high-quality research since its inception in 2000, and it continues to be a vital resource for those seeking to enrich their knowledge and foster innovation within the field of transplantation, fostering collaboration among practitioners, researchers, and students alike.

Transplantation Direct is a leading open access journal in the field of transplantation, published by the prestigious Lippincott Williams & Wilkins. Since its inception in 2015, the journal has provided a vital platform for the dissemination of high-quality research and advancements related to organ transplantation. With an impact factor that places it in the Q2 category among transplantation journals, it ranks #22 out of 54 in the Medicine - Transplantation Scopus classification, reflecting its significance and authority within the discipline. The journal not only covers a broad scope of topics related to transplantation but also encourages global collaboration and knowledge exchange amongst researchers, clinicians, and students. With its open access model, Transplantation Direct ensures that groundbreaking findings are accessible to a wider audience, fostering innovation and enhancing patient care worldwide. For more information, visit their address at TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103.

LIVER TRANSPLANTATION, published by Lippincott Williams & Wilkins, stands at the forefront of hepatology and transplantation research, with a prestigious Q1 rating across the categories of Hepatology, Surgery, and Transplantation as of 2023. Since its inception in 2000, this journal has been dedicated to disseminating high-quality, cutting-edge research that advances the understanding and practice of liver transplantation. With an impressive ranking of 23rd out of 551 in Surgery and 9th out of 54 in Transplantation, it occupies an esteemed position in the academic landscape, attracting contributions from leading experts in the field. The journal's rigorous peer-review process ensures the publication of impactful studies, innovative clinical practices, and vital insights into patient management. By fostering a collaborative environment for researchers, clinicians, and students alike, LIVER TRANSPLANTATION serves as an essential resource for those engaged in the complexities of liver transplantation and related fields. Join the community committed to advancing liver health and transplantation science.